Functional MRI detection of pharmacologically induced memory impairment
Reisa A. Sperling(Harvard University), Marilyn Albert(Alzheimer’s Disease Neuroimaging Initiative), Paul G. Firth(Massachusetts General Hospital), Ronald Killiany(Alzheimer’s Disease Neuroimaging Initiative), H. Diana Rosas(Harvard University), Nicholas Lange, Andrew Cocchiarella(Brigham and Women's Hospital), Douglas N. Greve(Victoria and Albert Museum), Jennifer Holmes(Boston University), Anders M. Dale(J. Craig Venter Institute), Stephen Lake(Boston University), Carol Routledge(Boston University), Bruce R. Rosen(Massachusetts General Hospital)
Cited by 211
Related Papers
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
|NeuroImage|2006|14.1k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k